Search research articles
Contact Us
Filters
Showing results (421-430 of 438) with videos related to
Page
of 44
Sort By:
Genome Medicine
|
April 20, 2021
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch
Leonor Sánchez-Busó, Corin A Yeats, Benjamin Taylor, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2021
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19
Suzette M Cameron-McDermott, Geoffrey J Barrow, Alicia M Webster, et al.
Genome Research
|
March 26, 2013
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture
Helena M B Seth-Smith, Simon R Harris, Rachel J Skilton, et al.
The Journal of Antimicrobial Chemotherapy
|
March 18, 2025
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdens
Daniel Schröder, Thitima Cherdtrakulkiat, Le Huu Doanh, et al.
IJID Regions
|
April 21, 2025
High susceptibility to the novel antimicrobial zoliflodacin among <i>Neisseria gonorrhoeae</i> isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024
Susanne Jacobsson, Thitima Cherdtrakulkiat, Daniel Golparian, et al.
Lancet (London, England)
|
December 14, 2025
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial
Alison Luckey, Manica Balasegaram, Lindley A Barbee, et al.
The Lancet Regional Health. Western Pacific
|
September 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study
Ismael Maatouk, Phiona Vumbugwa, Thitima Cherdtrakulkiat, et al.
Annals of the New York Academy of Sciences
|
August 10, 2011
The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms
David L Reed, Russell W Currier, Shelley F Walton, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2010
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
Muhamed-Kheir Taha, Sara Thulin Hedberg, Marek Szatanik, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2025
High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-24
Josefine Ahlstrand, Ismael Maatouk, Le Huu Doanh, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 438) with videos related to
Sort By:
Page
of 44
Genome Medicine
|
April 20, 2021
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch
Leonor Sánchez-Busó, Corin A Yeats, Benjamin Taylor, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2021
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19
Suzette M Cameron-McDermott, Geoffrey J Barrow, Alicia M Webster, et al.
Genome Research
|
March 26, 2013
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture
Helena M B Seth-Smith, Simon R Harris, Rachel J Skilton, et al.
The Journal of Antimicrobial Chemotherapy
|
March 18, 2025
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdens
Daniel Schröder, Thitima Cherdtrakulkiat, Le Huu Doanh, et al.
IJID Regions
|
April 21, 2025
High susceptibility to the novel antimicrobial zoliflodacin among <i>Neisseria gonorrhoeae</i> isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024
Susanne Jacobsson, Thitima Cherdtrakulkiat, Daniel Golparian, et al.
Lancet (London, England)
|
December 14, 2025
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial
Alison Luckey, Manica Balasegaram, Lindley A Barbee, et al.
The Lancet Regional Health. Western Pacific
|
September 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study
Ismael Maatouk, Phiona Vumbugwa, Thitima Cherdtrakulkiat, et al.
Annals of the New York Academy of Sciences
|
August 10, 2011
The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms
David L Reed, Russell W Currier, Shelley F Walton, et al.
Antimicrobial Agents and Chemotherapy
|
July 8, 2010
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
Muhamed-Kheir Taha, Sara Thulin Hedberg, Marek Szatanik, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2025
High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-24
Josefine Ahlstrand, Ismael Maatouk, Le Huu Doanh, et al.
Page
of 44